Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
- PMID: 30333506
- PMCID: PMC6193026
- DOI: 10.1038/s41598-018-33499-4
Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
Abstract
In the absence of a more effective vaccine against TB and in the interest of developing one, it is essential to understand immune responses associated with BCG protection. We comprehensively characterized T cell populations in BCG-vaccinated children over time. Blood from 78 healthy, BCG-vaccinated children representing four age groups (<1 yr, ≥1 yr <2 yr, ≥2 yr <5 yr, ≥5 yr), was stimulated in vitro for 24 hours and 6 days with live BCG to induce effector and central memory responses. Antigen-specific CD4, CD8, γδ and regulatory T cell populations were phenotyped and intracellular and secreted cytokines measured by flow cytometry and multiplex ELISA respectively. Our results demonstrated that populations of naïve T cells predominated in infants, compared to older children. However, BCG-specific effector CD4 T cell responses were equivalent and antigen-specific CD4 T cell proliferative capacity was increased in infants compared to older children. Increases in innate immune responses including γδ T cell responses and secreted pro-inflammatory cytokines were noted with increasing age. In conclusion, we identified that the capacity to expand and differentiate effector T cells in response to BCG stimulation wanes with increasing age, which may indicate waning central memory immunity. Booster vaccination could be considered to maintain the antigen-specific central memory pool and possibly enhance the duration of protection.
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.PLoS One. 2014 Nov 24;9(11):e113951. doi: 10.1371/journal.pone.0113951. eCollection 2014. PLoS One. 2014. PMID: 25419982 Free PMC article.
-
BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common γc cytokines in elderly individuals.PLoS One. 2021 Nov 10;16(11):e0258743. doi: 10.1371/journal.pone.0258743. eCollection 2021. PLoS One. 2021. PMID: 34758029 Free PMC article.
-
CD4 and CD8 T-cell responses to mycobacterial antigens in African children.Am J Respir Crit Care Med. 2010 Jul 1;182(1):120-9. doi: 10.1164/rccm.200912-1862OC. Epub 2010 Mar 11. Am J Respir Crit Care Med. 2010. PMID: 20224065 Free PMC article.
-
Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.Clin Exp Immunol. 2012 Sep;169(3):213-9. doi: 10.1111/j.1365-2249.2012.04614.x. Clin Exp Immunol. 2012. PMID: 22861360 Free PMC article. Review.
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
Cited by
-
Identification of cytokine signatures in HIV‑infected individuals with and without Mycobacterium tuberculosis co‑infection.Biomed Rep. 2024 Jul 10;21(3):131. doi: 10.3892/br.2024.1819. eCollection 2024 Sep. Biomed Rep. 2024. PMID: 39070110 Free PMC article.
-
BCG revaccination in adults enhances pro-inflammatory markers of trained immunity along with anti-inflammatory pathways.iScience. 2023 Sep 9;26(10):107889. doi: 10.1016/j.isci.2023.107889. eCollection 2023 Oct 20. iScience. 2023. PMID: 37817935 Free PMC article.
-
Is Immuno-modulation the Key to COVID-19 Pandemic?Indian J Orthop. 2020 Apr 27;54(3):394-397. doi: 10.1007/s43465-020-00121-7. eCollection 2020 May. Indian J Orthop. 2020. PMID: 32341599 Free PMC article. No abstract available.
-
BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny.Front Microbiol. 2020 Mar 11;11:332. doi: 10.3389/fmicb.2020.00332. eCollection 2020. Front Microbiol. 2020. PMID: 32218774 Free PMC article. Review.
-
Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosisΔleuDΔpanCD as an Alternative to H37Rv.Front Microbiol. 2019 Aug 20;10:1922. doi: 10.3389/fmicb.2019.01922. eCollection 2019. Front Microbiol. 2019. PMID: 31481950 Free PMC article.
References
-
- WHO Publication. Global Tuberculosis Control 2011. World Health OrganisationWHO/HTM/TB/2011.16, 1–258 (2011).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials